Jennifer Norton
Psychiatric/Mental Health · Des Moines, IANPI 1891034013
Payments from drug & device makers
Across 166 payments — averaging $18.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$315
- Otsuka America Pharmaceutical, Inc.$300
- Lundbeck LLC$266
- Johnson & Johnson$253
- Axsome Therapeutics, Inc.$252
- Teva Pharmaceuticals USA, Inc.$221
- plus $1K from 22 others
What the payments were for
- Food & beverage$3,074100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUNOSI$112
How this compares
$3,074 in reported general payments places this provider in the 80th percentile of 443 psychiatric/mental health providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $91,814 |
| Aripiprazole | 31 | $1,876 |
| Bupropion XlBupropion Hcl | 75 | $1,280 |
| Quetiapine Fumarate | 67 | $1,230 |
| Buspirone Hcl | 59 | $741 |
| Fluoxetine Hcl | 35 | $722 |
| Duloxetine Hcl | 41 | $614 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 20 | $572 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 41 | $518 |
| Clonazepam | 38 | $410 |
| Lamotrigine | 90 | $388 |
| Risperidone | 12 | $294 |
| Lorazepam | 30 | $287 |
| Alprazolam | 35 | $282 |
| Escitalopram Oxalate | 46 | $272 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $52 | $91,81411 claims |
| Almatica Pharma LLCSertraline Hcl | $38 | $718 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 443 psychiatric/mental health providers in Iowa.
Other psychiatric/mental health in Des Moines
- Quentin ChambersDes Moines$40K
- Cynthia CoenenDes Moines$8K
- Rachel FilzerDes Moines$5K
- Tarrah HollidayAtlantic$421K
- Kelsie SwisherParkersburg$235K
- Jennifer BradleyCedar Rapids$66K
- Kama AusbornWaterloo$64K
- Tenaea JeppesonFort Dodge$38K
- Jennifer WittmanCoralville$25K
- Amy MorinCedar Rapids$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.